INTRODUCTION
The inflammatory bowel diseases (IBD), ulcerative colitis (UC) and Crohn's disease (CD), are driven by complex interactions of genetic susceptibility traits, environmental factors, and enteric microbes.
1,2 Disturbances in T-cell homeostasis contribute to the pathogenesis of both chronic intestinal disorders. 2 
CD4
þ Th17 cells expressing the lineage-determining transcription factor RORgt accumulate in intestinal tissues of IBD patients and perpetuate colitis in mouse models. [2] [3] [4] In contrast, regulatory T cells (Tregs) expressing the lineage-defining transcription factor FoxP3 protect from colitis. 5 Although Tregs and Th17 cells exhibit opposing functions, they both can develop from the same pool of naïve CD4 þ T-cell precursors. Once differentiated, they even display a certain degree of environment-dependent plasticity, with Tregs converting into interleukin (IL)-17 producers or RORgt-expressing cells becoming positive for FoxP3 and the anti-inflammatory cytokine IL-10. 6 IL-2Ra, IL-2Rb, and the common gamma chain form the IL-2 receptor, which is essential for T-cell proliferation upon antigen encounter and the initiation of T-cell responses. 7 IL-2Ra and its ligand IL-2 also act, together with the nuclear Foxo proteins and Smad-mediated signals, as pivotal regulators of Treg function. 8, 9 Although IL-2 preferentially signals through STAT5 (ref. 10 ) and promotes the generation of Tregs, 11, 12 the Foxo transcription factors are tightly regulated by the phosphatidylinositide-3 kinase (PI3K) and Akt pathways, which induce the nuclear export of Foxo and thereby impede Treg activity. 13 Engagement of IL-2Ra minimizes the activation of Akt and PI3K pathways 9 and inhibits Th17-differentiation. 14 Although Tregs do not produce IL-2 themselves, 15, 16 they are the only T-cell population expressing constitutively IL-2Ra. 17 Tregs express unique sets of costimulatory molecules at steady state. 18 One of these abundantly expressed molecules is CD101. 19, 20 In vitro, CD101 þ Tregs are more suppressive than their CD101
À counterparts. 19 CD101 is also expressed on various myeloid cells, 19, 21, 22 which exhibit immunosuppressive functions 23 upon engagement of CD101 by agonistic antibodies. The mechanisms underlying the regulation and abundant expression of CD101 in close proximity to the intestinal lumen 24 and the interaction partner(s) of CD101 are unknown. The function of CD101 in vivo during intestinal inflammation has never been investigated.
Here, we analyzed the role of CD101 in mouse and human IBD. We observed that the transfer of naïve CD4 þ T cells 25 from CD101 À / À donors accelerated the onset of intestinal inflammation in recipient mice, which correlated with increased numbers of tissue-infiltrating T cells and enhanced IL-17 production. Although the intrinsic CD101 expression on T cells was sufficient for the concomitant expression of FoxP3 with IL-2Ra and the inhibition of T-cell proliferation, additional expression of CD101 by myeloid recipient cells was required for optimal Treg function. In IBD patients, a reduced CD101 expression on monocytes and CD4 þ T cells correlated with enhanced IL-17 production and disease activity identifying CD101 as a novel marker for IBD disease activity.
RESULTS

T cells become CD101
þ upon transfer
To study CD101 in vivo, we used the well-established T-cell transfer-colitis model 25 and first analyzed the expression of CD101 on donor and recipient cells. Although purified naïve CD4 þ CD45RB high IL-2Ra À T cells did not express CD101 before transfer, T cells became CD101-positive after transfer (Figure 1a) , particularly in the intestinal epithelium (IE); 8.1 ± 3.8%, 31.1 ± 5.4%, 26.8 ± 6.9%, or 18.7 ± 4.6% of all T cells in the IE were CD101 þ at week 1, 3, 5, or 7 after transfer (mean þ s.e.m. of two experiments). Before T-cell transfer, around 50% of CD11b þ and CD11c þ cells expressed CD101 in lymphopenic recipient mice (Figure 1b,c) , whereas CD101 was undetectable on intestinal epithelial cells (data not shown). After T-cell transfer, the numbers of CD101 þ myeloid cells in the organs of recipient mice decreased (Figure 1b,c) . Although the number of CD101 þ eosinophils remained unchanged (data not shown), transfer of CD101 þ / þ or CD101 À / À T cells caused a significant reduction of CD101 expression by CD11b þ Gr1 þ neutrophils and CD11b þ F4/80 þ macrophages (Supplementary Table 1 online) .
To evaluate whether the presence of CD101 in recipient mice influences CD101 expression by donor T cells, we performed comparative adoptive T-cell transfers into CD101
À / À and CD101 þ / þ recipients. Unlike to the regulation of CD101 on myeloid cells by transferred T lymphocytes, a lack of CD101 expression in recipient mice increased the frequency of CD101 þ donor T cells in the intestine (Figure 1d ) indicating a bidirectional impact of CD101 during the interaction of T cells and myeloid cells in vivo.
CD101 deficiency of donor T cells accelerates the onset of intestinal inflammation
To study the impact of CD101 on disease, we assessed intestinal pathology in RAG1 
þ ) was assessed by flow cytometry before (a, left panels for T cells obtained from mLNs; a-c, gray bars) and 3 weeks after the adoptive T-cell transfer (a-d). The mean percentages (±s.d.) of CD101 positivity within the respective cell populations were derived from the analysis of 28 (a) or 18
þ / þ mice and from 9 CD101 À / À recipient mice (d; one out of three experiments). Statistical significance was calculated using analysis of variance with Bonferroni post hoc test (*Po0.05; **Po0.01; ***Po0.001). IE, intestinal epithelium; mLN, mesenteric lymph nodes. 
, respectively, 3.5 weeks before were assessed by flow cytometry (c) or immunofluorescence microscopy (CD4 þ T lymphocytes are shown in red and intestinal epithelial cells in blue (d); (bar ¼ 100 mm; mean ± s.d. of three experiments). Statistical significant differences within the respective organ sites were calculated using a Student's t-test (**Po0.01). IE, intestinal epithelium; mLN, mesenteric lymph nodes.
transferred into CD101
À / À recipients ( Supplementary  Figure 1c) , severe colitis was even more rapidly detected than after the transfer of CD101 Figure 3d) . Thus, although both CD101 þ myeloid and CD101 þ lymphoid cells exhibit anti-colitogenic functions, the enhanced ability of CD101 À / À T cells to induce colitis primarily results from the loss of a T-cell intrinsic-negative regulatory function of CD101.
CD101 supports the differentiation and function of Tregs
The induction of colitis in the T-cell transfer model has been linked to an expansion of Th1 and Th17 cells. 3 Therefore, we tested the expression of cytokines and transcription factors associated with the generation of these Th-cell populations in the organs of CD101 Figure 4c) . In contrast, the knockout of CD101 on donor T lymphocytes alone was sufficient to promote the expression of IL-17 ( Figure 3a) .
To define the CD101-intrinsic effects on T-cell differentiation, we performed competitive index experiments and co-transferred naïve T cells from CD101 þ / þ mice or CD101 À / À mice allelically marked by CD45.1 or CD45.2 in a 1:1 mixture into RAG1 À / À mice (Supplementary Figure 2a) . T cells from CD101 þ / þ mice expressed also significantly more FoxP3 and less IL-17 than their CD101 À / À counterparts after co-transfer implying CD101 intrinsic effects on T-cell differentiation (Supplementary Figure 2c,d) .
The balance between Th17 and Tregs maintains intestinal immune homeostasis. 6 Whereas only few RORgt þ T cells were CD101 þ (6.9 ± 3.7% and 8.1 ± 4.3% CD101 þ for mesenteric lymph nodes (mLN) and IE, respectively; mean þ s.e.m. of 5 mice), Tregs abundantly expressed CD101 (Supplementary Figure 5a) . 19 Therefore, we analyzed the role of CD101 in the differentiation of Tregs. Although the CD4 To evaluate CD101 expression on FoxP3 þ T cells, we transferred purified natural Tregs (nTregs) from mice expressing FoxP3 under a green fluorescent protein (GFP) promoter 28 into recipient mice. Following transfer, the number of recovered CD101
þ FoxP3 þ T cells was significantly increased (Supplementary Figure 5a) . To test whether CD101 expression correlated with the suppressive capacity of Tregs as previously proposed, 19 we co-transferred nTregs from þ / þ T cells ( Figure 4a) . Still, the absolute number of CD101 À / À T cells accumulating in the single transfer studies was larger than in the co-transfer setup, which might be due to variabilities in the numbers of intraepithelial lymphocytes and/ or CD101-dependent, but cell-extrinsic mechanisms that affect, e.g., the production and/or consumption of cytokines.
Engagement of CD101 inhibited IL-2-production and proliferation of human T cells. 29, 30 To evaluate whether CD101 intrinsically inhibits the T-cell response to IL-2, which is essential for T-cell proliferation, 7, 31 we evaluated IL-2Ra/b and IL-2 expression of CD101 þ / þ and CD101 À / À T cells after co-transfer. Confirming this in vitro inhibitory effect of CD101, 29, 30 we observed that T cells from CD101 þ / þ mice expressed significantly less IL-2Ra and IL-2Rb than T cells from CD101 Figure 3c) .
To further prove that alterations in the production of and the responsiveness to IL-2 underlie the divergent recovery of T cells from CD101 À / À and CD101 þ / þ donors, we transferred CFSE-labeled T cells into RAG1 À / À mice and defined the divisions of T cells by carboxyfluorescein succinimidyl þ / þ or CD101 À / À donors. All cells were pre-gated on CD45, CD4, and TCRb before purification and intracellular cytokine staining (ICS) analysis. The ratio of the respective cytokine mRNA copies relative to the hypoxanthine-guanine phosphoribosyltransferase (HPRT) copies was calculated. The relative increase in IL-17 copy numbers of
cells is displayed (one out of two experiments). (b) The absolute numbers of FoxP3 þ cells (mean ± s.d.) isolated individually from the IE of 6 RAG1
À / À mice 4 weeks after the transfer of T cells from either CD101 þ / þ or CD101 À / À donors are displayed (one out of two experiments). Statistical significance was calculated using a Student's t-test (*Po0.05).
) littermates were co-transferred together with naïve T cells from Ly5.
(e,f) recipients. Intestinal inflammation was determined by endoscopy (c) and histopathology (e) and the relative number of FoxP3 þ cells among all T cells in the various tissues was measured by flow cytometry (d,f) 6 weeks after transfer (one out of four experiments). All cells were pre-gated on CD45 before.Statistical significance for eight individual recipient mice in each group was calculated using a Kruscal-Wallis test with Dunn's multiple comparison (*Po0.05; **Po0.01). mLN, mesenteric lymph nodes. Figure 6a) . We observed that CFSE dilution (i.e., T-cell proliferation) was much faster in recipients of CD101 À / À T cells than in mice that had received CD101 þ / þ T cells (Figure 4c ). The percentage of CD101 þ cells also gradually decreased with higher cell division cycles (Supplementary Figure 6b) , whereas the expression of IL-2Ra/b increased ( Supplementary Figure 6c) , further supporting that CD101 intrinsically inhibits T-cell proliferation because of the restriction of IL-2-production and IL-2Rab-expression. Accordingly, the addition of an IL-2-blocking antibody reduced the IL-2-induced expression of IL-2Ra on T cells and subsequently T-cell proliferation (Supplementary Figure 6d) . These data support the concept that CD101 intrinsically inhibits T-cell proliferation by restricting the production of IL-2 and, via downregulation of IL-2R-expression, also the responsiveness to IL-2.
ester (CFSE) dilution assays (Supplementary
CD101 inhibits the FoxP3-independent expression of IL-2Ra on T cells CD101 promoted the development of naïve T cells into Tregs (Figure 3b and Supplementary Figure 5b) , which are characterized by an IL-2-dependent differentiation and high IL-2Ra and FoxP3 expression. 9 At the same time, CD101
T cells expressed less IL-2Ra than their CD101 À / À counterparts (Figures 1a, 4b) . To further unravel the link between CD101, FoxP3, and IL-2Ra, we compared the expression of IL-2Ra and CD101 on 
CD101
À / À FoxP3-GFP littermates 28 as Tregs lose their FoxP3 expression when adoptively transferred into lymphopenic hosts (Supplementary Figure 3e) . Within the FoxP3 À subset significantly less T cells expressed IL-2Ra when originating from CD101 þ / þ FoxP3-GFP as compared with CD101 À / À FoxP3-GFP donors (Figure 4d) . Although the numbers of IL-2Ra þ cells among the FoxP3 þ subset were comparable between CD101 þ / þ and CD101 À / À donors after the transfer of purified Tregs or naïve T cells (Supplementary Figures 7a, 7b) , the recipients of T cells from CD101 þ / þ mice showed an increase in FoxP3 expression within the IL-2Ra þ T-cell population when compared with naïve T cells (Figure 4e and Supplementary Figure 7c Figure 7d) . Furthermore, although hardly any IL-2Ra/CD101-doublepositive cells were detected within the FoxP3 À T-cell compartment (Figures 1a and 4f) , FoxP3 þ cells contained a large population of IL-2Ra/CD101-coexpressing cells before 19 and after transfer (Figure 4f) . Thus, CD101 does not only promote the induction, but also the maintenance of FoxP3 expression and coordinates the co-expression of FoxP3 and IL-2Ra in response to IL-2. In contrast, FoxP3
À cells express IL-2Ra without upregulating CD101 simultaneously.
CD101 modulates signaling pathways to promote Treg and to suppress Th17 differentiation
To corroborate the role of CD101 for the simultaneous stabilization of FoxP3 and IL-2Ra on a molecular basis, we assessed the mRNA expression of the IL-2 target genes SOCS 2 and TGFb1 (ref. 32 and evaluated the activation of STAT5, a major component of the IL-2 signaling pathway, 11, 12 in rIL-2-stimulated T-cell cultures obtained from the mLNs of recipient mice after transfer of purified CD101 þ / þ and CD101
Tregs. Although SOCS2 transcription ( Figure 5a ) and STAT5 phosphorylation (Figure 5b and c) were increased in CD101 þ / þ compared with CD101 À / À T cells, TGFb1 expression remained unaltered (Supplementary Figure 7d) . SOCS2 transcription was also enhanced in the mLNs of naïve CD101 þ / þ compared with CD101 À / À mice upon IL-2 stimulation (data not shown), suggesting an enhanced sensitivity of T cells to IL-2 signals in the presence of CD101. Thus, CD101 promotes the differentiation and function of Tregs by fostering distinct IL-2-mediated signaling pathways.
The absence of CD101 did not only largely abolish FoxP3 expression (Figure 3b ), but also enhanced T-cell proliferation ( Figure 4c ) and IL-17 production (Figure 3a) . We therefore assessed the regulation of signaling pathways and target genes that are critical for the differentiation of Tregs and Th17 cells, 8, 33 in tissues of recipient mice after the transfer of naïve T cells or purified Tregs. The expression of COX2, which has been associated with Th17 differentiation, 34, 35 was strikingly reduced in recipients of naïve CD101 þ / þ compared with CD101 À / À T cells (Figure 5d ). The phosphorylation of ERK1, which restrains the generation of Tregs 36 and is upstream of COX2, but not of the Akt pathways, 37 was similarly decreased in the organs of recipients of naïve T cells (Figure 5e ) and purified Tregs (Figure 5f ) from CD101 þ / þ donors. The phosphorylation of the PI3K-dependent serine/threonine kinase Akt, which induces the nuclear export of the Foxo transcription factors, 8, 13 was also decreased in transferred purified Tregs from CD101 þ / þ donors ( Figure 5g) . As PI3K phosphorylation itself was only marginally altered between CD101 þ and CD101 À T cells (data not shown), CD101 engagement likely affects the differentiation of Th17 cells through an alternative pathway of Akt-activation independent of PI3K.
CD101 expression by T cells or myeloid cells mutually regulates the production of IL-10
The expression of CD101 on T cells ameliorated the colitis (Figure 2a and b) and was sufficient for the generation of Tregs (Figure 3b ) and the inhibition of T-cell proliferation (Figure 4c) . In contrast, CD101 on myeloid cells had no impact on the severity of the colitis induced by CD101 Figure 3a,b) , which raises questions on the exact role of myeloid cells for the regulation of intestinal homeostasis.
T cells (Supplementary
We first evaluated the distribution of myeloid cells in recipient mice before and after T-cell transfer. Compared with naïve RAG1
T cells had an increased frequency of CD11b þ cells in the spleen and mLNs (Figure 6a) . Although Gr1 þ and F4/80 þ cells were enriched within the CD11b þ population, there were no significant changes detected for Siglec-F þ or CD11c þ cells (data not shown). Also, upon transfer of CD101 þ / þ T cells, the frequency of CD11b þ cells was augmented in the spleens and mLNs of CD101 þ / þ -and CD101 À / À -recipient mice ( Figure 6b) .
Next, we investigated whether CD101 is involved in the regulation of IL-10, which exhibits potent anti-inflammatory effects, 38 regulates the growth, function, and/or differentiation of multiple cell types, 39, 40 and protects against IBD or severe enterocolitis in humans and mice, respectively. 41, 42 To assess the effect of CD101 on the expression of IL-10, we transferred naïve T cells from CD101 þ / þ or CD101 À / À VERT-X mice, an IL-10-GFP transcriptional reporter strain, 43 into CD101
À / À mice and transferred naïve T cells as well as Tregs from CD101 þ / þ and CD101 À / À FoxP3-GFP þ T cells 3 weeks after transfer were stimulated with 50 ng ml À 1 rIL-2 (a,b) or 100 ng ml À 1 anti-CD3 (b). mRNA (a) and protein lysates (b) from purified T cells were extracted 30 min later. SOCS2 mRNA copies were determined by reverse transcription-quantitative PCR (RT-qPCR; a). The ratio of the Socs2 mRNA copies relative to the HPRT copies was calculated. The ratios Socs2/ HPRT in each panel were set to 1 for the tissues of one control sample. STAT5 expression and phosphorylation was analyzed by western blotting (b). Western blot signals were quantitated using Image J software (c; one out of three (a,b) experiments). (d-g) The expression of mRNA copies for COX2 (d) as well as the expression and phosphorylation of ERK (e, f) and Akt (g) were evaluated in the mLNs of 9-12 recipient mice 4 weeks after the transfer of naïve T cells (d,e) or purified Tregs (f,g) from CD101
þ / þ and CD101 À / À mice. mRNA was extracted and COX2 mRNA copies were determined by RT-qPCR (d). The ratio of the COX2 mRNA copies relative to the HPRT copies was calculated. The relative increase in COX2 copy numbers of CD101 À / À over CD101 þ / þ donor T cells is displayed. Representative western blots for ERK1 and Akt are displayed (e-g; one out of three experiments). Statistical significance was calculated using a Student's t-test for each experimental condition separately (**Po0.01). HPRT, hypoxanthine-guanine phosphoribosyltransferase; mLN, mesenteric lymph nodes; NS, not stimulated.
CD101-expression correlates inversely with the severity of IBD in humans
Having seen that CD101 has a strong impact on the severity of colitis in mice, we evaluated CD101 expression on lymphoid and myeloid cell subsets of IBD patients. Compared with peripheral blood T lymphocytes from control individuals, CD and UC patients, particularly those with active disease, exhibited a markedly reduced frequency of CD4 þ T cells that co-expressed CD101 (Figure 7a and Supplementary  Figure 8a) . Furthermore, significantly fewer CD101-expressing CD11b þ cells were recovered from the peripheral blood of UC and CD patients as compared with controls ( Figure 7b) . Within that CD11b þ population, the number of CD14 þ CD15 À monocytes was significantly reduced (7.8 ± 10.9 vs. 2.9 ± 2.2; mean þ s.e.m. of 28 controls and 36 IBD patients; Po0.05).
To investigate CD101 expression within the intestine, we obtained tissue samples from UC patients undergoing selective colectomy because of a failure of conservative treatment (n ¼ 4) and non-IBD control patients (n ¼ 6). CD101 was almost completely absent from CD4 þ T lymphocytes (1.53±1.24 vs. 11.48 ± 9.67; mean þ s.e.m. of 6 controls and 4 UC patients; 
not receive any T cells (gray bars). The numbers of CD11b
þ cells in the spleens, mLNs and the intestinal epithelium (IE) were determined by flow cytometry. Statistical significance was calculated using analysis of variance (ANOVA) with Bonferroni post hoc test (one out of two experiments). (*Po0.05; **Po0.01).
The numbers of IL-10-GFP þ T cells (c) and of IL-10 þ CD11b þ myeloid cells (d) as well as the percentages of IL-10 þ CD11b þ myeloid cells expressing CD101 simultaneously (e) were determined by flow cytometry. Representative FACS dot plots for the co-expression of CD101 and IL-10 on CD11b þ CD11c þ myeloid cells from the intestinal epithelium are displayed (f). All cells were pre-gated on CD45 before (one out of two experiments). Statistical significance for eight individual recipients mice of T cells from CD101 þ / þ and CD101 À / À donors was calculated using a Student's t-test for each organ separately (c) or using ANOVA with Bonferroni post hoc test (d; *Po0.05). mLN, mesenteric lymph nodes.
P ¼ 0.08) and CD11b
þ myeloid cells in colon specimens of UC patients as compared with controls (8.34±7.71 vs. 35.27±11.21; mean þ s.e.m. of 6 controls and 4 UC patients; Po0.01). Furthermore, whereas more than 90% of IL-2Ra-expressing T cells were positive for CD101 in the control group, less than 20% of the IL-2Ra þ cells co-expressed CD101 in UC patients (Figure 7c and Supplementary Figure 8b) , suggesting that the expression of IL-2Ra is usually linked to the expression of CD101 under physiologic conditions. The drastic reduction in the expression of CD101 protein was associated with similar changes of the expression of CD101 mRNA in both CD and UC patients (Figure 7d) . Underlining a dominant role of Th17 cells in the pathogenesis of IBD, 2, 3 we detected significantly increased levels of IL-17A-mRNA in T cells of CD or UC patients compared with non-IBD controls (Figure 7e ) and an inverse expression of CD101 and IL-17A ( Supplementary  Figure 8c) , although the Th17-related transcription factor RORgt was comparably expressed in all three groups (Figure 7f) .
Collectively, these data document a reduced intestinal and peripheral CD101 expression and an enhanced IL-17 production in IBD patients.
DISCUSSION
The data presented here support the concept that loss of CD101 expression is a novel marker for progressive IBD. The association of a reduced CD101 expression on CD4 þ T cells with an increased disease activity in UC and CD patients was mirrored by the results obtained in the mouse model of T-cell transfer-induced colitis, which allowed detailed analyses of the mechanism of action of CD101. Whereas a lack of CD101 on transferred T cells clearly correlated with more severe colitis, the clinical phenotypes of CD101
À / À and CD101 þ / þ recipient mice after the transfer of CD101 þ / þ T cells were comparable. This latter observation is best explained by the enhanced recovery of CD101 þ and FoxP3 þ T cells from CD101 À / À recipients, which compensate the reduced Treg function mediated by CD101 À myeloid cells. In IBD patients, the expression of CD101 was reduced on myeloid and lymphoid cells, suggesting that both cell populations are unable to properly exhibit their compensatory anti-inflammatory functions.
CD101, IL-2, and Tregs
Our mechanistic analyses point to an unexpected dichotomic activity of CD101 on IL-2 production and signaling. On the one hand, CD101 restricted IL-2R expression and IL-2 release. The resulting lack of IL-2 protein likely limits T-lymphocyte expansion and/or survival, although the T-cell intrinsic CD101 expression was already sufficient for the inhibition of T-cell proliferation. Thus, it is conceivable that CD101 acts as a critical modulator of the recently suggested IL-2 dependent quorum sensing-like mechanisms between IL-2-positive T cells and Tregs 44 because of its negative regulatory functions on IL-2 production and IL-2R expression. On the other hand, CD101 amplified the IL-2-mediated SOCS2 expression and STAT5 phosphorylation, both of which reflect an improved IL-2 signaling 10,45 and thus, might reflect an enhanced consumption of IL-2, e.g., because of a larger number of CD101 þ / þ T cells differentiating into Tregs. Consequently, the question arises how these seemingly contradictory molecular events associated with the engagement of CD101 nevertheless lead to a uniform phenotypic effect on a defined T-cell subset. Although IL-2 and IL-2R are pivotal for T-cell proliferation and expansion in general, they are in particular critical for the stability of FoxP3 expression and Treg function. 46 Based on our observation that CD101 coordinated the expression of IL-2Ra and FoxP3 on a single-cell level, we postulate that CD101 sensitizes Tregs for IL-2 and stabilizes IL-2 signaling, despite the overall reduced expression of IL-2 and IL-2Ra within the FoxP3 À T cell compartment in CD101 þ / þ compared with CD101 À / À mice. Furthermore, the engagement of CD101 might contribute to the FoxP3-dependent repression of the IL-2 gene. 15, 16 CD101 and the Treg/Th17 balance In the presence of CD101, the transformation of naïve T cells into colitogenic, IL-17 þ T cells was attenuated and the phosphorylation of ERK and Akt was blocked. Akt is a PI3K-dependent serine/threonine kinase, which induces the nuclear export of Foxo transcription factors and thereby antagonizes the function of Tregs. 8, 13, 47 Similar to Akt, ERK restrains the generation of Treg 36 and promotes the proliferation of naïve T cells and their differentiation into Th17 cells. 48, 49 Thus, CD101 modulates signaling cascades downstream of the T-cell receptor (TCR) in such a way that the development of Tregs is facilitated, whereas the generation of Th17 cells is inhibited. Importantly, a deficiency of CD101 in T cells promoted the production of IL-17, which fosters T cellmediated pathology in lymphopenic recipients, 4 but this was not sufficient for an enhanced production of interferon-g, which requires an additional deletion of CD101 on myeloid cells (Supplementary Figure 4c) and/or another modulation of myeloid cells in addition to CD101 suppression as observed during bacterial infection. 22 Although this enhanced interferon-g production by CD101
À / À T cells stipulated the more severe enterocolitis in CD101 À / À recipients, an augmented IL-2 and IL-17 production, an increased IL-2Ra/b expression and an enhanced T-cell accumulation contributed to the more severe intestinal inflammation in CD101 þ / þ recipients after the transfer of T cells from CD101 À / À compared with CD101 þ / þ donors.
CD101 and myeloid cells
CD101 is not only expressed on lymphoid, but also myeloid cell populations. 19, 21, 22 We previously observed that the expression of CD101 was lost on granulocytes, macrophages, and dendritic cells following infection. 22 As the expression of MHC class II antigens was at the same enhanced, we believe that the downregulation of CD101 is a critical event in the initiation of effective anti-bacterial immune responses. 22 In the present study, we show that CD101 was critical for the sustained production of the anti-inflammatory cytokine IL-10. Furthermore, the function of and the differentiation into Tregs was most potent, when both donor and recipient cells expressed CD101 (see Figures 3b-f and Supplementary Figure 2c for details). Thus, the enhanced IL-10 production in CD101-competent recipients and/or protective interactions between CD101 þ myelojd and CD101 þ lymphoid cells most likely reduces the pathogenicity of transferred T cells and helps to explain the comparable clinical outcome in CD101 þ / þ vs. CD101 À / À recipients, despite a reduced T-cell accumulation in the latter ones (see Supplementary Figures 3a-c for details) . Whether certain bacterial species promote the expression of CD101 and IL-10 is part of our ongoing analyses.
In conclusion, we describe a novel anti-inflammatory function of CD101 in mice and identify the loss of CD101 as a potential marker for progressive IBD in humans. CD101 serves as a dual regulator of lymphoid and myeloid cell subsets: first, CD101 acts as a stabilizer of FoxP3 expression via distinct IL-2-dependent mechanisms. It promotes the generation of Tregs and suppresses the conversion of naïve into IL-17-producing T cells by interfering with various signaling pathways and inhibiting FoxP3-independent IL-2Ra expression and T-cell expansion. Second, CD101
þ myeloid cells support the function of Tregs (Supplementary Figure 9) . Future studies need to delineate the exact mechanisms and signaling pathways that connect CD101 with the promotion of SOCS2 and STAT5 expression and the suppression of Akt/ERK signaling, to define the extracellular ligand(s) of CD101, and to identify the molecular pathways regulating the expression of CD101. 0 and 3), leading to a cumulative score between 0 (no signs of inflammation) and 15 (very severe inflammation).
Histology and hematoxylin and eosin staining. Intestinal tissue was fixed in 10% buffered formalin, embedded in paraffin, and cut into 2-mm-thick sections. Colonic and ileal sections were deparaffinized, stained with hematoxylin and eosin by the Department of Pathology and the Medical Department I of the Friedrich-Alexander Universität Erlangen-Nürnberg, and evaluated microscopically in a doubleblinded manner. Briefly, the intestinal damage shown in the presented figures was evaluated using the following parameters: (i) inflammatory infiltrate of the lamina propia, (ii) thickness of the subepithelial collagenous layer, (ii) presence of intraepithelial lymphocytes, and (iv) epithelial damage. A histologic grading of the severity of the tissue damage was performed for each parameter (score between 0 and 3), leading to a cumulative score between 0 (no signs of inflammation) and 12 (very severe inflammation and epithelial damage).
Immunofluorescence microscopy. Cryosections obtained from intestinal samples of mice were incubated with primary rat-antibodies against mouse CD4 (Pharmingen) overnight. Subsequently, the sections were incubated for 1 h with a secondary antibody against rat IgG (Dianova, Hamburg, Germany). For the detection of doublepositive cells, anti-mouse CD101 antibody (R&D Systems, Wiesbaden, Germany) was biotinylated and labeled with Alexa555-conjugated streptavidin. The nuclei were counterstained with Hoechst 3342 (Invitrogen, Carlsbad, CA). Images were taken with a fluorescence microscope (IX70; Olympus, Shinjuku-ku, Tokyo).
Human tissue samples. The collection of human samples was approved by the local Ethics Committee and the Reviewing Board of the University of Erlangen-Nürnberg (number 4032). Each patient gave written informed consent. Human peripheral blood mononuclear cells were obtained after Ficoll centrifugation of heparinized blood of IBD patients and healthy controls. Colonic biopsies of sigmoid colon and rectum from UC patients and biopsies of ileum and colon from CD patients with a score of 3 were investigated in this study along with samples from non-inflammatory controls (diverticulosis, cancer screening, functional bowel disorders) with a score of 0.
Flow cytometry and intracellular cytokine staining. Antibodies against mouse TCRb, CD4, CD101, CD25, Cd122, CD45.1, CD45.2, FoxP3, CD11b, and CD11c were purchased from eBioscience (San Diego, CA). Antibodies against human CD3, CD4, CD25, and CD11b were purchased from eBioscience; anti-human CD101 was obtained from Abcam (Cambridge, UK). Intracellular staining for Foxp3 and intracellular cytokines was performed with a staining kit (eBioscience) following the manufacturer's instructions. Cells were analyzed on a BD FACS Canto II (BD Biosciences, San Diego, CA) with FlowJo software (Tree Star, Ashland, OR).
Statistical analysis. Samples were analyzed for normal distribution by a Kolmogorov-Smirnov test. According to the results, statistical significance in normal distributed samples were analyzed by one-way analysis of variance with post-hoc test (Bonferroni) and Student's t-test, and samples failing the normal distribution test by Kruscal-Wallis test with post hoc (Dunn's multiple comparison) or Mann-Whitney U-test as indicated in the respective experiments. A sample size of at least three (n ¼ 3) was used for each sample group in a given experiment, and a P value of 5% (*Pr0.05), 1% (**Pr0.01), or 0.1% (***Pr0.001) was considered significant to accept the alternate hypothesis. GraphPad Prism software (La Jolla, CA) was used for statistical analysis.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
